New Biden Executive Order Targets Hospital Mergers & Drug Pricing, Renews Antitrust Focus
Last week, the Biden Administration unveiled a sweeping executive order, focused on promoting competition in the US economy. With Lina Khan as the new chairperson of the Federal Trade Commission, the ...
16 Jul 202114min
No Surprises Act: Known Impacts on Surprise Medical Bills & What's Next
Last week, the Biden administration issued an interim final rule to implement critical components of the No Surprises Act (NSA).Building on the Affordable Care Act, the NSA includes new patient protec...
9 Jul 202114min
Home-based Care Left Out of Bipartisan Infrastructure Plan
President Joe Biden has been making negotiations to get his massive infrastructure plan over the finish line. Some funding related to health care that was originally in the plan ended up on the cuttin...
2 Jul 202110min
Unpacking Apple's health care efforts and digital health's overall maturity
Tech giants like Apple and Alphabet, the parent company of Google, have been trying to push into health care for some time now. But pursuing health care as a business is hard. Recent news of Google re...
25 Jun 202112min
Peering into the MedPAC crystal ball for the future of Medicare payments
June is shaping to be a busy month in the health policy space. Two major events happened this week alone.First, the Affordable Care Act (ACA) survived its latest legal challenge in the Supreme Court. ...
17 Jun 20219min
Insights into FDA's controversial decision to approve a new Alzheimer's treatment drug
This week, the US Food and Drug Administration approved Aduhelm (aducanumab) to treat patients with Alzheimer's disease using an accelerated approval pathway.The drug was approved on June 7, 2021, and...
11 Jun 202113min
States are leading the way on the public option
President Joe Biden included the public health insurance option, commonly referred to as the "public option," as a major pillar of his health care platform during the 2020 presidential campaign.To dat...
4 Jun 202114min
Does the US have a drug innovation problem?
Last week, Representative Katie Porter took AbbVie CEO Richard Gonzalez to task on drug pricing during a House Oversight and Reform Committee hearing. Porter highlighted the CEO's high salary while po...
28 Mai 20219min
